BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18214793)

  • 21. L- and M-cone-driven electroretinograms in Stargardt's macular dystrophy-fundus flavimaculatus.
    Scholl HP; Kremers J; Vonthein R; White K; Weber BH
    Invest Ophthalmol Vis Sci; 2001 May; 42(6):1380-9. PubMed ID: 11328755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular genetic analysis of ABCR gene in Japanese dry form age-related macular degeneration.
    Fuse N; Suzuki T; Wada Y; Yoshida M; Shimura M; Abe T; Nakazawa M; Tamai M
    Jpn J Ophthalmol; 2000; 44(3):245-9. PubMed ID: 10913642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different clinical expressions in two families with Stargardt's macular dystrophy (STGD1).
    Eksandh L; Ekström U; Abrahamson M; Bauer B; Andréasson S
    Acta Ophthalmol Scand; 2001 Oct; 79(5):524-30. PubMed ID: 11594993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical defects in ABCR protein variants associated with human retinopathies.
    Sun H; Smallwood PM; Nathans J
    Nat Genet; 2000 Oct; 26(2):242-6. PubMed ID: 11017087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ABCA4 sequence variants in Chinese patients with age-related macular degeneration or Stargardt's disease.
    Baum L; Chan WM; Li WY; Lam DS; Wang PB; Pang CP
    Ophthalmologica; 2003; 217(2):111-4. PubMed ID: 12592048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isotretinoin treatment inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration.
    Radu RA; Mata NL; Nusinowitz S; Liu X; Travis GH
    Novartis Found Symp; 2004; 255():51-63; discussion 63-7, 177-8. PubMed ID: 14750596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical electrophysiology of two rod pathways: normative values and clinical application.
    Scholl HP; Langrová H; Weber BH; Zrenner E; Apfelstedt-Sylla E
    Graefes Arch Clin Exp Ophthalmol; 2001 Feb; 239(2):71-80. PubMed ID: 11372548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Next generation sequencing in the diagnosis of Stargardt's disease.
    Jimenez-Rolando B; Noval S; Rosa-Perez I; Mata Diaz E; Del Pozo A; Ibañez C; Silla JC; Montaño VEF; Martin-Arenas R; Vallespin E
    Arch Soc Esp Oftalmol (Engl Ed); 2018 Mar; 93(3):119-125. PubMed ID: 28571903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed dark-adaptation and lipofuscin accumulation in abcr+/- mice: implications for involvement of ABCR in age-related macular degeneration.
    Mata NL; Tzekov RT; Liu X; Weng J; Birch DG; Travis GH
    Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1685-90. PubMed ID: 11431429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cosegregation and functional analysis of mutant ABCR (ABCA4) alleles in families that manifest both Stargardt disease and age-related macular degeneration.
    Shroyer NF; Lewis RA; Yatsenko AN; Wensel TG; Lupski JR
    Hum Mol Genet; 2001 Nov; 10(23):2671-8. PubMed ID: 11726554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ABCR gene in recessive and dominant Stargardt diseases: a genetic pathway in macular degeneration.
    Zhang K; Kniazeva M; Hutchinson A; Han M; Dean M; Allikmets R
    Genomics; 1999 Sep; 60(2):234-7. PubMed ID: 10486215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectrum of ABCR gene mutations in autosomal recessive macular dystrophies.
    Rozet JM; Gerber S; Souied E; Perrault I; Châtelin S; Ghazi I; Leowski C; Dufier JL; Munnich A; Kaplan J
    Eur J Hum Genet; 1998; 6(3):291-5. PubMed ID: 9781034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ATP binding cassette transporter retina genotypes and age related macular degeneration: an analysis on exudative non-familial Japanese patients.
    Kuroiwa S; Kojima H; Kikuchi T; Yoshimura N
    Br J Ophthalmol; 1999 May; 83(5):613-5. PubMed ID: 10216065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations in ABCR (ABCA4) in patients with Stargardt macular degeneration or cone-rod degeneration.
    Briggs CE; Rucinski D; Rosenfeld PJ; Hirose T; Berson EL; Dryja TP
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2229-36. PubMed ID: 11527935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene therapy for Stargardt disease associated with ABCA4 gene.
    Han Z; Conley SM; Naash MI
    Adv Exp Med Biol; 2014; 801():719-24. PubMed ID: 24664763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Inherited retinal diseases in patients with ABCA4 gene mutations].
    Sheremet NL; Grushke IG; Zhorzholadze NV; Tanas AS; Strelnikov VV
    Vestn Oftalmol; 2018; 134(4):68-73. PubMed ID: 30166513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A dominant Stargardt's macular dystrophy locus maps to chromosome 13q34.
    Zhang K; Bither PP; Park R; Donoso LA; Seidman JG; Seidman CE
    Arch Ophthalmol; 1994 Jun; 112(6):759-64. PubMed ID: 8002833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Null missense ABCR (ABCA4) mutations in a family with stargardt disease and retinitis pigmentosa.
    Shroyer NF; Lewis RA; Yatsenko AN; Lupski JR
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2757-61. PubMed ID: 11687513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding the etiology of Stargardt's disease.
    Glazer LC; Dryja TP
    Ophthalmol Clin North Am; 2002 Mar; 15(1):93-100, viii. PubMed ID: 12064087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation and characterization of a Stargardt's disease-specific induced pluripotent stem cell line (LVPEIi008-A) with a homozygous nonsense mutation in exon 44 of ABCA4.
    Pidishetty D; Maddileti S; Mahato S; Agrawal T; Naik M; Kannabiran C; Jalali S; Mariappan I
    Stem Cell Res; 2024 Aug; 78():103458. PubMed ID: 38870564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.